Cover Image

Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2

BackgroundThis study explores the risk factors associated with viral shedding time in elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron.MethodsParticipants infected with SARS-CoV-2 omicron were enrolled in a retrospective study, and divided i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weijie Zhong (Author), Xiaosheng Yang (Author), Xiufeng Jiang (Author), Zhixin Duan (Author), Wei Wang (Author), Zhaoliang Sun (Author), Wanghao Chen (Author), Wenchuan Zhang (Author), Jie Xu (Author), Juan Cheng (Author), Xiaoling Yuan (Author), Yi Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study
by: Lei Pei, et al.
Published: (2023)

Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study
by: Wen Zhang, et al.
Published: (2022)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022)

Epidemiological characteristics of a local COVID-19 outbreak caused by Omicron (BA.2.2) variant in Henan province
by: Jing-jing PAN, et al.
Published: (2022)

Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients
by: Shaojun He, et al.
Published: (2022)

Prolonged rectal shedding of SARS-CoV-2 in a 22-day-old-neonate: a case report
by: Julie Niemann Holm-Jacobsen, et al.
Published: (2021)

Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Diseases: Modeling Approach to SARS-CoV-2 Alpha and Omicron Infection
by: Ting-Yu Lin, et al.
Published: (2024)

Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76
by: Urvashi B. Singh, et al.
Published: (2023)

Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study
by: Xiaqing Zhang, et al.
Published: (2023)

Case report: Severe acute hepatitis in a 22-month-old Chinese boy with Omicron sub-variant BA.2.38
by: Xinying Chen, et al.
Published: (2022)

Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai
by: Ran Li, et al.
Published: (2023)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
by: Chengzhuo Tong, et al.
Published: (2022)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
by: Francesca Dapporto, et al.
Published: (2022)

Outcome of Transplant Recipients Infected with Omicron BA.1 and BA.2: A Single-Center Retrospective Study in Saudi Arabia
by: Abeer N. Alshukairi, et al.
Published: (2023)

Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
by: Peng Yang, et al.
Published: (2023)

Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers
by: Meenakshi Sharma, et al.
Published: (2022)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022)

Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan
by: Kimiko Tomioka, et al.
Published: (2023)

Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market
by: Mingyu Luo, et al.
Published: (2023)

Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
by: Danying Yan, et al.
Published: (2021)

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak
by: Wenjing Ye, et al.
Published: (2023)

Prolonged Leptospira Urinary Shedding in a 10-Year-Old Girl
by: Emilie Chow, et al.
Published: (2012)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
by: Freja Cordelia Møller Kirsebom, et al.
Published: (2022)

Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic
by: Wenlong Zhu, et al.
Published: (2023)

Corrigendum: Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market
by: Mingyu Luo, et al.
Published: (2023)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022)

Transmission characteristics of a COVID-19 outbreak caused by Omicron variant BA.5.2 in Yiwu city, China
by: Xiaoxiao WANG, et al.
Published: (2023)

Real world effectiveness of sotrovimab in preventing COVID-19-related hospitalisation or death in patients infected with Omicron BA.2
by: Alwaleed Behzad, et al.
Published: (2024)

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
by: Francisco P Freire-Neto, et al.
Published: (2022)

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants
by: Kana Fujimoto, et al.
Published: (2022)

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding
by: Monique A.L.J. Slaats, et al.
Published: (2020)

Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75
by: Shengnan Yin, et al.
Published: (2022)

Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2+
by: Akimasa Iijima, et al.
Published: (2023)

The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
by: Jih-Jin Tsai, et al.
Published: (2024)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
by: Cong Xu, et al.
Published: (2023)

In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
by: Rahatul Islam, et al.
Published: (2023)

Wastewater-based epidemiology: the crucial role of viral shedding dynamics in small communities
by: Marc-Denis Rioux, et al.
Published: (2023)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
by: Xiaosu Chen, et al.
Published: (2023)

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2023)

Trajectories of SARS-CoV-2 viral shedding among admitted patients at a tertiary-care center in California, 2020-2022
by: Ralph Tayyar, et al.
Published: (2023)